MARÍA ESTHER
MANCEBO SIERRA
Investigadora en el període 2012-2019
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (7)
2024
-
Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch
Transplantation, Vol. 108, Núm. 3, pp. 787-801
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2016
-
High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients
Immunobiology, Vol. 221, Núm. 5, pp. 595-603
-
High frequency of central memory regulatory t cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation
International Immunology, Vol. 28, Núm. 2, pp. 55-64
-
High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients
Transplant Immunology, Vol. 34, pp. 33-41
2015
-
Activated Regulatory T Cells Expressing CD4+CD25highCD45RO+CD62L+ Biomarkers Could Be a Risk Factor in Liver Allograft Rejection
Transplantation Proceedings, Vol. 47, Núm. 8, pp. 2380-2381